Hla Y Myint, Jonathan Berman, Larry Walker, Brandon Pybus, Victor Melendez, J Kevin Baird, Colin Ohrt
Index: Am. J. Trop. Med. Hyg. 85(6) , 1010-4, (2011)
Full Text: HTML
Because 8-aminoquinolines affect critical survival stages of Plasmodium parasites, treatment and control of malaria could be markedly improved by more widespread use of these drugs; however, hemolytic toxicity, which is widely prevalent in G6PD-deficient patients, severely constrains this use. Primaquine was approved more than 50 years ago after extensive clinical testing. Review of the mid-20th century literature in the light of present understanding of pharmacokinetics and metabolism suggests that manipulation of these factors might dissociate 8-aminoquinoline efficacy from toxicity and lead to an improved therapeutic index.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
8-Aminoquinoline
CAS:578-66-5 |
C9H8N2 |
|
CYP450 phenotyping and accurate mass identification of metab...
2012-01-01 [Malaria Journal 11 , 259, (2012)] |
|
Aminoquinolines as fluorescent labels for hydrophilic intera...
2012-08-01 [Biol. Chem. 393(8) , 757-65, (2012)] |
|
Copper chelator induced efficient episodic memory recovery i...
2012-01-01 [PLoS ONE 7(8) , e43105, (2012)] |
|
Humanized mouse model of glucose 6-phosphate dehydrogenase d...
2013-10-22 [Proc. Natl. Acad. Sci. U. S. A. 110(43) , 17486-91, (2013)] |
|
Leishmaniasis: current status of available drugs and new pot...
[Asian Pac. J. Trop. Med. 5(6) , 485-97, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
